Health Ministry says recoveries are double the active Corona cases

▴ Health Ministry says recoveries are double the active Corona cases
India prepares for Vande Bharat phase 5 as Corona status in the country improves

The Health Ministry has said that the COVID-19 recoveries have crossed the one-million mark in the country. Briefing the media in New Delhi yesterday, the Officer of Special Duty in the Health Ministry said, the recovery rate among COVID-19 patients increased from 7.85 per cent in April to 64.44 per cent at present.

He said the recoveries are 1.9 times the number of active cases of COVID-19. The Health Ministry Official said effective clinical management led to a decline in the COVID-19 case fatality rate from 3.33 per cent on 18th June to 2.21 percent yesterday. He said, due to enhanced testing infrastructure, on an average 468263 COVID-19 tests conducted daily from 26th to 30th July.

India has achieved another landmark with more than 6 lakh tests done in 24 hours. The Health Ministry said it is continuing to implement the strategy of comprehensive testing, tracking and treatment to effectively tackle the COVID19 pandemic. It said, the objective is to raise the testing capacity to 10 lakhs tests per day in the medium term.

Meanwhile, Phase Five of the Vande Bharat Mission is scheduled to start from the first of August. Under Phase Four of the Vande Bharat Mission, a total of 1197 flights have been scheduled so far. These include 945 international flights and 252 feeder flights.

These flights were operated by the Air India group, Indigo, Spicejet and Go Air and cover 29 countries. They have repatriated nearly one lakh of people. This phase is expected to continue until 2nd August. He said they expect another 80 thousand people to be repatriated by that time.

IN PHASE 5 a total of 792 flights which include 692 international flights and 100 domestic flights have been scheduled under this phase to repatriate Indians from 23 countries. These include GCC countries, the US, Canada, UK, Germany, France, Australia, New Zealand, Malaysia, Philippines, Singapore, Bangladesh, Myanmar, Thailand, China, Israel, and Kyrgyzstan.

Briefing media this evening, External Affairs Ministry spokesperson Anurag Srivastava said, these flights would cater to 21 different airports in India and repatriate a total of one lakh thirty thousand Indians stranded abroad. A total of 878921 Indian nationals have returned till yesterday so far under the Mission. Of these, 107452 Indians have returned from Nepal, Bhutan, Myanmar, Pakistan and Bangladesh through land borders.
 

Tags : #RecoveryRate #HealthMinistry #VandeBharatPhase5 #Coronastatus #AIRIndia #Spicejet #Indigo #CovidNewsUpdate

About the Author


Team Medicircle

Related Stories

02 Aug

Sweet Poison: Heavy Metal Contamination in Chocolate

While chocolates and cocoa-based products are generally safe to consume in moderation, it is essential to be aware of the potential risks associated with heavy metal contamination.

View
18 Mar

FDA Greenlights Lupin's Varenicline Tablets: A Game-Changer in Smoking Cessation Therapy

Lupin Limited's FDA approval for its generic Varenicline tablets marks a significant milestone in the field of smoking cessation therapy.

View
17 Nov

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need for broader insurance coverage to ensure accessibility for a larger population.

View
16 Nov

Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India Launch

As Valneva works towards making this groundbreaking vaccine available in India, the collaboration with CEPI and Instituto Butantan underlines the global effort to address infectious diseases. The upcoming regulatory interactions with DCGI will shed light on the timeline for Ixchiq's launch in India.

View
11 Nov

Historic Breakthrough: FDA Grants Accelerated Approval for Valneva’s Ixchiq - The First Chikungunya Vaccine

As the vaccine moves towards global markets, its impact on public health is poised to be substantial. The ongoing commitment to safety studies and pediatric evaluations reflects a dedication to comprehensive healthcare solutions. The pharmaceutical landscape is witnessing a transformative moment, and Ixchiq stands at the forefront of this medical breakthrough.

View
03 Nov

A New Hope for Sickle Cell Patients: Groundbreaking Gene Therapy Under FDA Review

Unlike current treatments that include drugs, blood transfusions, and bone marrow transplants, exa-cel aims to provide a one-time, DNA-altering solution. By modifying the patient's blood cells, the therapy targets the root cause of the disease, promoting the production of healthy haemoglobin.

View
23 Oct

Indian Medtech Startup Sigtuple Receives U.S. FDA approval; becomes India's 1st company in this space to earn the clearance

For all haematological disorders like blood cancers, infections, anaemia & allergies, the microscopic examination of the peripheral blood smear (PBS) is the gold standard test, but microscopy today is predominantly a manual process - necessitating a highly skilled pathologist to be present on-site.

View
06 Oct

Safety Concerns Arise: FDA Investigates Probiotic-Related Infant Death

Probiotics are live microorganisms believed to enhance health when consumed adequately, while they offer potential health benefits, this incident highlights the importance of careful consideration, especially in vulnerable populations like preterm infants.

View
05 Aug

FDA Approves Groundbreaking Postpartum Depression Oral Pill - Zurzuvae (Zuranolone)

Postpartum depression (PPD) affects countless new mothers worldwide, casting a shadow over what should be a joyful time in their lives. For years, healthcare professionals have been searching for an effective treatment for this debilitating condition. In a momentous development, the U.S. Food and Drug Administration (FDA) has recently approved the first-ever postpartum depression oral pill, Zurzuvae (Zuranolone).

View
23 Feb

4D pharma announces FDA clearance of IND application for Live Biotherapeutics MRx0005 and MRx0029

Latest Pharma news

View

-Advertisements-




Trending Now

Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
10 New HIV Cases in 2 Months: Has Kerala’s Drug Problem Gone Too Far?March 28, 2025
Type 2 Diabetes Under Attack: The Unexpected Power of Wearable TechMarch 28, 2025
Research identifies causes of catastrophic floodingMarch 28, 2025
Why a Few Extra Inches Around Your Waist Could Cost You Your LifeMarch 28, 2025
Young IT Professional Answers Call To Be Stem Cell DonorMarch 28, 2025
5 Hidden Signs of Nutrient Deficiency You Shouldn’t IgnoreMarch 28, 2025